Dr Manzanilla DM is a Oral Syrup in the Human Otc Drug category. It is labeled and distributed by Key Therapeutics. The primary component is Dextromethorphan Hydrobromide; Phenylephrine Hydrochloride; Triprolidine Hydrochloride.
Product ID | 70868-704_274f9f97-155c-44bd-83d8-6b8ef3d17be8 |
NDC | 70868-704 |
Product Type | Human Otc Drug |
Proprietary Name | Dr Manzanilla DM |
Generic Name | Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, Triprolidine Hydrochloride |
Dosage Form | Syrup |
Route of Administration | ORAL |
Marketing Start Date | 2019-08-11 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part341 |
Labeler Name | Key Therapeutics |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE |
Active Ingredient Strength | 20 mg/5mL; mg/5mL; mg/5mL |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-08-11 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-08-11 |
Marketing End Date | 2020-03-31 |
Ingredient | Strength |
---|---|
DEXTROMETHORPHAN HYDROBROMIDE | 20 mg/5mL |
SPL SET ID: | 37388ab0-27c7-47de-8bdd-1a2d164047d7 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |